enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ultrafiltration (kidney) - Wikipedia

   en.wikipedia.org/wiki/Ultrafiltration_(kidney)

   Slow continuous ultrafiltration (SCUF) is an artificial method which approximately mimics the ultrafiltration function of the kidneys. SCUF is a continuous renal replacement therapy (CRRT) generally used to remove fluid from fluid overloaded patients with acute kidney failure.

3. Renal replacement therapy - Wikipedia

   en.wikipedia.org/wiki/Renal_replacement_therapy

   Before implementing continuous renal replacement therapy (CRRT), acute renal failure (ARF) in critically ill, multiple organ failure patients was managed by intermittent hemodialysis and the mortality rate was very high. [4] Hemodialysis is effective in clearance and ultrafiltration, but it has deleterious effects on hemodynamic stability. [5]

4. Hemofiltration - Wikipedia

   en.wikipedia.org/wiki/Hemofiltration

   Before implementing continuous renal replacement therapy (CRRT), acute renal failure (ARF) in critically ill, multiple organ failure patients was managed by intermittent hemodialysis and the mortality rate was very high. [11] Hemodialysis is effective in clearance and ultrafiltration, but it has deleterious effects on hemodynamic stability. [12]

5. Nuwellis Welcomes University of Iowa Health Care Stead Family ...

   lite.aol.com/tech/story/0022/20241031/9264805.htm

   The Stead Family Children’s Hospital will use the Aquadex SmartFlow system to provide adjustable ultrafiltration therapy for critically ill children experiencing excess fluid buildup. This therapy will allow for safe and effective fluid removal, which is critical in managing severe heart and kidney conditions.

6. Nuwellis Secures New Patent for Innovative Pediatric ...

   lite.aol.com/tech/story/0022/20240625/9168906.htm

   MINNEAPOLIS, June 25, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the recent grant of a new patent from the United States Patent and Trademark Office (USPTO) related to its groundbreaking pediatric continuous renal replacement therapy (CRRT), Vivian™.

7. New Study Published in Current Problems in Cardiology ...

   lite.aol.com/tech/story/0022/20240827/9221106.htm

   MINNEAPOLIS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce the publication of a new study in Current Problems in Cardiology demonstrating the effectiveness of Aquadex® ultrafiltration therapy in reducing 60 day hospital readmission rates for patients with ...

8. Artificial kidney - Wikipedia

   en.wikipedia.org/wiki/Artificial_kidney

   This failure typically occurs over a long period of time, and when the patient's renal function declines enough over the course of the disease, is commonly known as end stage renal disease (ESRD; which is also known as Level 5 or 6 kidney disease, depending on whether dialysis or renal replacement therapy is used).

9. Nuwellis Receives Increased Reimbursement Rate for Aquadex ...

   lite.aol.com/tech/story/0022/20241104/9266597.htm

   This increase in reimbursement corresponds with the reassignment of therapeutic ultrafiltration CPT code 0692T from APC 5241 to APC 5242. The decision by CMS marks a significant milestone in the recognition of the value and effectiveness of Aquadex SmartFlow ultrafiltration therapy for treating fluid overload in heart failure patients.